- Home
- ACXP vs TACT Comparison
ACXP vs TACT Comparison
Compare ACXP & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- TACT
- Stock Information
- Founded
- ACXP 2017
- TACT 1996
- Country
- ACXP United States
- TACT United States
- Employees
- ACXP N/A
- TACT N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- TACT Computer peripheral equipment
- Sector
- ACXP Health Care
- TACT Technology
- Exchange
- ACXP Nasdaq
- TACT Nasdaq
- Market Cap
- ACXP 8.4M
- TACT 35.7M
- IPO Year
- ACXP 2021
- TACT 1996
- Fundamental
- Price
- ACXP $0.47
- TACT $3.85
- Analyst Decision
- ACXP Strong Buy
- TACT Strong Buy
- Analyst Count
- ACXP 2
- TACT 1
- Target Price
- ACXP $10.00
- TACT $5.00
- AVG Volume (30 Days)
- ACXP 18.7M
- TACT 13.8K
- Earning Date
- ACXP 08-08-2025
- TACT 08-07-2025
- Dividend Yield
- ACXP N/A
- TACT N/A
- EPS Growth
- ACXP N/A
- TACT N/A
- EPS
- ACXP N/A
- TACT N/A
- Revenue
- ACXP N/A
- TACT $45,750,000.00
- Revenue This Year
- ACXP N/A
- TACT $14.81
- Revenue Next Year
- ACXP N/A
- TACT N/A
- P/E Ratio
- ACXP N/A
- TACT N/A
- Revenue Growth
- ACXP N/A
- TACT N/A
- 52 Week Low
- ACXP $0.30
- TACT $3.12
- 52 Week High
- ACXP $3.33
- TACT $5.11
- Technical
- Relative Strength Index (RSI)
- ACXP 52.38
- TACT 59.80
- Support Level
- ACXP $0.45
- TACT $3.49
- Resistance Level
- ACXP $0.59
- TACT $3.83
- Average True Range (ATR)
- ACXP 0.08
- TACT 0.22
- MACD
- ACXP -0.01
- TACT 0.03
- Stochastic Oscillator
- ACXP 27.06
- TACT 72.22
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.